Literature DB >> 8043291

Preconditioning the human heart during aorto-coronary bypass surgery.

A M Alkhulaifi1, D M Yellon, W B Pugsley.   

Abstract

UNLABELLED: Ischaemic preconditioning, with brief periods of ischaemia separated by reperfusion, increases myocardial resistance to infarction. In addition, preconditioning leads to preservation of myocardial adenosine triphosphate (ATP) during ischaemia. We propose that ischaemic preconditioning may share fundamental similarities with intermittent aortic cross-clamping utilised during aorto-coronary bypass surgery. The aim of this study was to test the hypothesis that controlled aortic cross-clamping is a form of preconditioning using conservation of ATP as the end point. Patients randomised to the preconditioned group (preconditioned, n = 10 patients), received a preconditioning stimulus of two 3-min periods of cross-clamping separated by 2 min of reperfusion prior to an ischaemic insult of 10 min ischaemia and ventricular fibrillation. In the control group (control, n = 10 patients) hearts received 10 min cross-clamping with fibrillation without prior preconditioning. Myocardial ATP, creatine phosphate (CP), and lactate were determined from biopsy specimens taken at the onset of cardiopulmonary bypass (A), at the end of preconditioning (B), and at the end of 10 min of ischaemic insult (C).
RESULTS: expressed as mean +/- SE (mumol/g dry weight). Preconditioning resulted in a significant depletion of the myocardial ATP content (preconditioned, B: 11.7 +/- 0.9 vs A: 19.8 +/- 1.4; P < 0.01). Furthermore 10 min of ischaemia resulted in a significant depletion of ATP in the control patients (control, C: 7.2 +/- 0.3 vs B: 19.5 +/- 1.2; P < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043291     DOI: 10.1016/1010-7940(94)90159-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

Authors:  Yan Lu; Liwei Wang; Na Liu; Tianxin Dong; Ruhong Li
Journal:  J Anesth       Date:  2016-08-16       Impact factor: 2.078

3.  Cardioprotective effect of ischemic preconditioning on global myocardial ischemia in a sheep right heart bypass model.

Authors:  Yoshihisa Tanoue; Paul Herijgers; Bart Meuris; Veerle Leunens; Marleen Lox; Willem Flameng
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-01

4.  Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium.

Authors:  Mahesh Thirunavukkarasu; Zhihua Han; Lijun Zhan; Suresh Varma Penumathsa; Venugopal P Menon; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2008-08       Impact factor: 8.401

Review 5.  Hyperbaric oxygen preconditioning: a reliable option for neuroprotection.

Authors:  Qin Hu; Anatol Manaenko; Nathanael Matei; Zhenni Guo; Ting Xu; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2016-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.